Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper
Authors
Keywords
-
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 23, Issue 11, Pages 2567-2576
Publisher
Springer Nature
Online
2012-01-19
DOI
10.1007/s00198-011-1870-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
- (2011) P. Hadji et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it
- (2011) Matteo Lazzeroni et al. BREAST
- New developments for treatment and prevention of bone metastases
- (2011) Jean-Jacques Body CURRENT OPINION IN ONCOLOGY
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
- (2011) Michael F. Holick et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older
- (2011) Andrew N. Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial
- (2010) R. Eastell et al. ANNALS OF ONCOLOGY
- Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: A Peripheral Quantitative Computed Tomography (pQCT) study
- (2010) K.A. Szabo et al. BONE
- Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study
- (2010) Robert E. Coleman et al. BREAST CANCER RESEARCH AND TREATMENT
- Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study
- (2010) Daniel Prieto-Alhambra et al. BREAST CANCER RESEARCH AND TREATMENT
- Assessment of fracture risk in women with breast cancer using current vs emerging guidelines
- (2010) P Hadji et al. BRITISH JOURNAL OF CANCER
- Satisfaction With Initial Screen and Compliance With Biennial Breast Screening at Centers With and Without Nurses
- (2010) Sarah A. Edwards et al. CANCER NURSING
- Emerging drugs for the management of cancer treatment induced bone loss
- (2010) Francesco Bertoldo et al. EXPERT OPINION ON EMERGING DRUGS
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The diagnosis of osteoporosis
- (2010) John A. Kanis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Women and Bone Health: Maximizing the Benefits of Aromatase Inhibitor Therapy
- (2010) Shou-Ching Tang ONCOLOGY
- Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
- (2009) M. Rabaglio et al. ANNALS OF ONCOLOGY
- Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency
- (2009) Heike A. Bischoff-Ferrari et al. ARCHIVES OF INTERNAL MEDICINE
- Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer
- (2009) Mirieme Ghazi et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Update of the BIG 1–98 Trial: Where do we stand?
- (2009) Markus Joerger et al. BREAST
- Meta-analysis of vitamin D, calcium and the prevention of breast cancer
- (2009) Peizhan Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study
- (2009) Georgiana K. Ellis et al. BREAST CANCER RESEARCH AND TREATMENT
- Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
- (2009) Adam M. Brufsky et al. Clinical Breast Cancer
- FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial
- (2009) Meghan G Donaldson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bisphosphonates in Oncology: Rising Stars or Fallen Heroes
- (2009) T. Van den Wyngaert et al. ONCOLOGIST
- Benefit–risk assessment of vitamin D supplementation
- (2009) H. A. Bischoff-Ferrari et al. OSTEOPOROSIS INTERNATIONAL
- Global vitamin D status and determinants of hypovitaminosis D
- (2009) A. Mithal et al. OSTEOPOROSIS INTERNATIONAL
- Practical guidance for the management of aromatase inhibitor-associated bone loss
- (2008) P. Hadji et al. ANNALS OF ONCOLOGY
- Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole
- (2008) Nigel J. Bundred et al. CANCER
- Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group
- (2008) David M. Reid et al. CANCER TREATMENT REVIEWS
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer
- (2008) Stephanie L. Hines et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
- Vitamin D deficiency: a global perspective
- (2008) Ann Prentice NUTRITION REVIEWS
- Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole
- (2008) A. Brufsky et al. ONCOLOGIST
- Vitamin D status and response to treatment in post-menopausal osteoporosis
- (2008) S. Adami et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started